Evaluation of ADA activity as a potential marker of disease severity in psoriasis patients
Seraj Ahmed Khan,1 Sudha Agrawal,2 Nirmal Baral,1 Madhab Lamsal1 1Department of Biochemistry, B.P. Koirala Institute of Health Sciences, Dharan, Nepal; 2Department of Dermatology and Venereology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal Background: Psoriasis is a dermatological disor...
Guardado en:
Autores principales: | Khan SA, Agrawal S, Baral N, Lamsal M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d43bdaa3b3b46d097629b64fc967c48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
por: Anani HAA, et al.
Publicado: (2020) -
Pustular psoriasis: pathophysiology and current treatment perspectives
por: Benjegerdes KE, et al.
Publicado: (2016) -
Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Aimilios Lallas, et al.
Publicado: (2016) -
Updates on the Treatment of Erythrodermic Psoriasis
por: Lo Y, et al.
Publicado: (2021) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021)